Adam Stone
Oprichter bij ARYA SCIENCES ACQUISITION CORP V
Vermogen: 229 665 $ op 31-05-2024
Profiel
Adam Leo Stone is the founder of ARYA Sciences Acquisition Corp.
(founded in 2018), ARYA Sciences Acquisition Corp.
II (founded in 2020), ARYA Sciences Acquisition Corp.
III (founded in 2020), ARYA Sciences Acquisition Corp.
IV (founded in 2020), ARYA Sciences Acquisition Corp.
V (founded in 2021), and Perceptive Capital Solutions Corp.
(founded in 2024).
He is currently the Chief Executive Officer & Director at Arya Sciences Holdings and LianBio.
He is also an Independent Director at Solid Biosciences, Inc., a Director at Xontogeny LLC, a Non-Executive Director at Immatics NV, the Chief Investment Officer at Perceptive Advisors LLC, and the Chief Investment Officer & Head of Research at Perceptive Advisors (Private Equity).
Mr. Stone has previously worked as a Director at PROMETHERA Biosciences SA, Prometheus Biosciences, Inc., and Renovia, Inc. (MA), as well as a Senior Analyst at Ursus Capital Management LLC.
He completed his undergraduate degree at Princeton University in 2001.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
IMMATICS N.V.
0.02% | 31-01-2024 | 20 313 ( 0.02% ) | 224 052 $ | 31-05-2024 |
LIANBIO
0.02% | 15-02-2024 | 17 082 ( 0.02% ) | 5 612 $ | 31-05-2024 |
SOLID BIOSCIENCES INC.
-.--% | 31-03-2024 | 0 ( -.--% ) | - $ | 31-05-2024 |
Actieve functies van Adam Stone
| Bedrijven | Functie | Begin |
|---|---|---|
| SOLID BIOSCIENCES INC. | Directeur/Bestuurslid | 01-11-2015 |
| IMMATICS N.V. | Directeur/Bestuurslid | 01-07-2020 |
| ARYA SCIENCES ACQUISITION CORP IV | Oprichter | 24-08-2020 |
| LIANBIO | Algemeen Directeur | 16-12-2023 |
| ARYA SCIENCES ACQUISITION CORP V | Oprichter | 22-02-2021 |
Perceptive Advisors LLC
 Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Chief Investment Officer | 01-05-2006 |
Arya Sciences Holdings
 Arya Sciences Holdings MiscellaneousMiscellaneous Arya Sciences Holdings operates as an investment holding American company. The private company is based in New York. The CEO of the company is Adam Leo Stone. | Algemeen Directeur | - |
Xontogeny LLC
 Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Directeur/Bestuurslid | - |
Perceptive Advisors (Private Equity)
 Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Chief Investment Officer | 01-01-2006 |
Eerdere bekende functies van Adam Stone
| Bedrijven | Functie | Einde |
|---|---|---|
| ░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░░░░░ ░░░░░░░░░░░ ░░░ ░ | ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Adam Stone
| Princeton University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| SOLID BIOSCIENCES INC. | Health Technology |
| IMMATICS N.V. | Health Technology |
| LIANBIO | Health Technology |
| ARYA SCIENCES ACQUISITION CORP IV | Finance |
| Bedrijven in privébezit | 12 |
|---|---|
Perceptive Advisors LLC
Perceptive Advisors LLC Investment ManagersFinance Perceptive Advisors LLC is an independent, SEC-registered investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Joseph “Joe” Edelman in 1999. provides investment advice to private funds, separate accounts, and co-investment vehicles. Investors in the client accounts and co-investment vehicles consist primarily of institutional investors, financial institutions, other investment funds, and high-net-worth individuals. | Finance |
Ursus Capital Management LLC
 Ursus Capital Management LLC Investment ManagersFinance Ursus Capital Management LLC is a hedge fund manager based in New York City. | Finance |
PROMETHERA Biosciences SA
 PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium. | Health Technology |
Perceptive Advisors (Private Equity)
Perceptive Advisors (Private Equity) Investment ManagersFinance Perceptive Advisors (Private Equity) (Perceptive Advisors) is a private equity subsidiary of Perceptive Advisors LLC founded in 1999 by Joseph Eric Edelman. The firm is headquartered in New York. | Finance |
Prometheus Biosciences, Inc.
 Prometheus Biosciences, Inc. BiotechnologyHealth Technology Prometheus Biosciences, Inc. engages in operation of a biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel precision therapeutics and companion diagnostics for patients living with unmet needs in gastroenterology and autoimmune diseases. The company was founded by Scott Glenn and Stephan Targan on October 26, 2016 and is headquartered in San Diego, CA . | Health Technology |
Renovia, Inc. (MA)
 Renovia, Inc. (MA) Medical SpecialtiesHealth Technology Renovia, Inc. engages in the development of sensor technologies combined with a digital health platform. The firm allows visualization and treatment of weakened pelvic floor muscles in real time, while collecting actionable compliance and progress data on women?s pelvic health. The company was founded by Marc Beer, Ramon Iglesias, Yolanda Lori? and James Frigge in August 2016 and is headquartered in Boston, MA. | Health Technology |
Xontogeny LLC
Xontogeny LLC Pharmaceuticals: MajorHealth Technology Xontogeny LLC operates biotech aggregator company. The firm offers entrepreneurs with guidance and operational support in drug and technology development. The company was founded by Christopher Nishan Garabedian and is headquartered in Boston, MA. | Health Technology |
ARYA Sciences Acquisition Corp.
 ARYA Sciences Acquisition Corp. Financial ConglomeratesFinance ARYA Sciences Acquisition Corp. is an organized blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, and reorganization or similar business combination with one or more entities. The company was founded by Joseph Eric Edelman, Adam Stone and Michael Altman in June 2018 and is headquartered in New York, NY. | Finance |
Arya Sciences Holdings
Arya Sciences Holdings MiscellaneousMiscellaneous Arya Sciences Holdings operates as an investment holding American company. The private company is based in New York. The CEO of the company is Adam Leo Stone. | Miscellaneous |
ARYA Sciences Acquisition Corp. II
 ARYA Sciences Acquisition Corp. II Financial ConglomeratesFinance ARYA Sciences Acquisition Corp. II is blank check company which formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which refer to as its initial business combination. The company was founded by Joseph Edelman, Adam Stone & Michael Altman on February 20, 2020 and is headquartered in New York, NY. | Finance |
ARYA Sciences Acquisition Corp. III
 ARYA Sciences Acquisition Corp. III Financial ConglomeratesFinance ARYA Sciences Acquisition Corp III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities, which it refers to as its initial business combination. It has not yet selected any business combination target. The company was founded by Joseph Edelman, Adam Stone, Michael Altman, and Konstantin Poukalov on March 27, 2020 and is headquartered in New York, NY. | Finance |
ARYA Sciences Acquisition Corp. V
 ARYA Sciences Acquisition Corp. V Financial ConglomeratesFinance Arya Sciences Acquisition Corp. V is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Adam Stones, Joseph Eric Edelman, Michael R. Altman, and Konstantin Poukalov on February 22, 2021 and is headquartered in New York, NY. | Finance |
